Navigation Links
Elekta Provides VMAT and Radiosurgery Solutions for New Jersey Health System
Date:6/18/2009

FREEHOLD, N.J., June 18 /PRNewswire/ -- CentraState Medical Center (Freehold, New Jersey) has purchased two new state-of-the-art Elekta radiation therapy treatment systems, both with Volumetric Modulated Arc Therapy (VMAT). The first site in the world to have both Elekta Axesse and Elekta Infinity, CentraState will offer the most advanced cancer care available to its patients.

CentraState Medical Center, a part of the CentraState Healthcare System, currently is treating 45 to 50 patients a day - with fluctuations as high as 70 patients per day, all on one treatment unit. When the time came to add another treatment system, CentraState elected to replace another manufacturer's system and install two new Elekta systems.

Jan Dragotta, Clinical Director, Radiation Oncology, says the decision process took several months and involved a team of CentraState physicians, physicists and administrators.

"In order to determine which technologies, both standard and emerging, had the most value, we completed a complex analysis to determine our current market and potential for growth," she said. "We all felt radiosurgery and motion management were the areas we wanted to grow, and that was supported by The Advisory Board Company in Washington D.C., which projected that, in the next 10 years, the biggest growth in cancer treatment will occur in radiosurgery."

One key determining factors in choosing Elekta was CentraState's desire to partner with a company that would ensure the institution would remain ahead of the technological curve.

Robert Smith, MS, Director of Physics, says, "Elekta's reputation has grown in recent years, so we spent a lot of time comparing Elekta with other systems, and discovered that Elekta systems had many advantages over the competition, especially in imaging capabilities. We decided to make the switch to Elekta."

"We'll be replacing our current IMRT techniques with VMAT," he explains. "We're looking to VMAT to increase throughput, but more importantly to reduce treatment times for our patients. That, in turn, will reduce the chance of patient movement during the treatment, another big concern, especially in lung and abdomen applications. We feel we can deliver a better, more precise treatment to the patient by delivering the dose in a shorter time."

Edward Soffen, M.D., Medical Director, says, "VMAT is the newest, latest, greatest technology for conforming the beam as closely as possible to the target. Although we're doing a good job now sparing healthy tissue, we're taking it to the next level of sophistication with VMAT. It's really advanced technology that will force others to be competitive with us, in terms of providing the most sophisticated technology available. We wanted the latest tools that really hone in on the tumor, give us better image guidance, and are compatible with our other hardware and software."

The new Elekta systems will be installed in August 2010. "As a team, we've spent a lot of time and effort evaluating treatment systems," says Dr. Soffen, "and I commend our administration for allowing us to have the best available tools to treat our patients."

"The management team at Elekta has a desire to develop clinically relevant techniques, and we have found Elekta to be far more personable and approachable than the other corporations," adds Robert Smith. They will definitely work with us to give our patients the best treatments possible."

For the latest Elekta VMAT news, visit elekta.com/vmat.

About Elekta

Elekta is a human care company pioneering significant innovations and clinical solutions for treating cancer and brain disorders. The company develops sophisticated state of the art tools and treatment planning systems for radiation therapy and radiosurgery, as well as workflow enhancing software systems across the spectrum of cancer care.

Today, Elekta solutions are used in more than 5,000 hospitals, and every day more than 100,000 patients receive diagnosis, treatment or follow-up with the help of a solution from the Elekta Group. Elekta employs around 2,500 people globally. Corporate headquarter is located in Stockholm, Sweden and the company is listed on the Nordic Exchange under the ticker EKTAb. For more information, visit www.elekta.com.

About CentraState

CentraState Healthcare System is a non-profit community health organization consisting of an acute-care hospital, an ambulatory care campus, three senior living communities, a Family Medicine Residency Program, and a charitable foundation. CentraState is a member of the Robert Wood Johnson Health Network and a clinical research affiliate of The Cancer Institute of New Jersey, a National Cancer Institute-designated Comprehensive Cancer Center.


'/>"/>
SOURCE Elekta
Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. Mass Financial Corp. Launches Lawsuit Against Elekta AB, Seeks Substantial Damages
2. Xoft Signs Sales Development Agreement With Elekta
3. Elekta and Mary Bird Perkins Cancer Center Sign Strategic Multi-Center Radiation Therapy Systems Agreement
4. Elekta Launches Web-based Virtual Clinic, Offers Better Understanding of Radiotherapy Solutions for the Treatment of Cancer
5. Elekta Family of Companies to Highlight Cancer Treatment Solutions at 2008 AAPM Annual Meeting
6. CMS, Inc., an Elekta Company, Receives FDA 510(k) Clearance for Atlas-Based Autosegmentation Software
7. Elekta Finds New Interest in Leasing Solutions as Hospitals Debate Capital Purchases
8. Hospitals Turn to Vendors Like Elekta for Help in Squeezing Most From Existing Technologies
9. Elekta Chosen to Deliver Sophisticated Brain Mapping Technology to the Mind Research Network
10. Elekta Sponsors All Are Our Heroes to Raise Cancer Awareness
11. Elekta Contract Provides MAGNET Cooperative Access to Leading Radiation Therapy Solutions
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/27/2017)... ... , ... Harris Communications, Inc., a leading provider of assistive technology for ... Deaf Seniors of America Conference, April 4-7 at the Hotel Westin Galleria in Houston. ... staff from Harris Communications and to try out the newest assistive devices available to ...
(Date:3/25/2017)... ... , ... Getting earned media coverage meaningful for Garden Media Group's clients is ... year, Garden Media aims to provide material helpful to clients’ goals and bottom lines. ... key messages to gain coveted media placements, Garden Media wows clients year-round. , ...
(Date:3/24/2017)... (PRWEB) , ... March 24, 2017 , ... ... solutions for contaminated soil, dredged material, and hazardous and non-hazardous materials announced today ... Allentown, Pennsylvania. This acquisition will add four additional processing facilities and a ...
(Date:3/24/2017)... ... March 24, 2017 , ... Mediaplanet today ... conversation on the current obstacles facing infection prevention and offer strategies for the ... by these infections. , The print component of “Fighting Infection” is distributed ...
(Date:3/24/2017)... ... March 24, 2017 , ... Digital Scientists, a software innovation lab specializing in ... a Greenville, South Carolina location. The lab has set up shop at ... been working with South Carolina clients for years from our office here in Atlanta,” ...
Breaking Medicine News(10 mins):
(Date:3/27/2017)... and BOSTON , March 27, ... global pharmaceutical company and Paratek Pharmaceuticals, Inc. (Nasdaq: ... and commercialization of innovative therapies based upon tetracycline ... of sarecycline for the treatment of moderate to ... endpoints. Sarecycline is a once-daily, oral, narrow spectrum ...
(Date:3/27/2017)... 27, 2017  PhaseRx, Inc. (NASDAQ: PZRX), a ... liver diseases in children, today reported financial results ... December 31, 2016 and provided an update on ... to make progress during the fourth quarter of ... our non-human primate safety study, and with our lead ...
(Date:3/24/2017)... , Mar 24, 2017 Research ... Therapy Manufacturing Market, 2017-2027" report to their offering. ... The Cell ... the rapidly growing market of cell therapy manufacturing and focuses ... manufacturing facilities. These therapies are anticipated to emerge as viable ...
Breaking Medicine Technology: